CCS
QDEL icon

Crosspoint Capital Strategies’s QuidelOrtho QDEL Stock Holding History

Crosspoint Capital Strategies’s Portfolio QDEL Stock Details QDEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-114
Closed -$7K – 44
2018
Q3 		$7K Sell
114
-23,350
-100% -$1.63M 0.01% 55
2018
Q2 		$1.56M Buy
+23,464
New +$1.42M 2.98% 11

Other funds holding QDEL

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Crosspoint Capital Strategies's QDEL Position: Q4 2018 in Review

Crosspoint Capital Strategies sold out of QuidelOrtho (QDEL) in Q4 2018, closing a stake of 114 shares — an estimated $7K sold.

Crosspoint Capital Strategies first reported a position in QDEL in Q2 2018 and held it in 2 quarters. The position peaked at $1.56M in Q2 2018. 158 funds tracked by Wall St. Rank hold QDEL as of Q4 2018.

  • Crosspoint Capital Strategies reported no remaining QuidelOrtho position as of Q4 2018 after selling out during the quarter.
  • Crosspoint Capital Strategies sold 114 QuidelOrtho shares in Q4 2018, an estimated $7K.
  • Crosspoint Capital Strategies first reported a position in QuidelOrtho in Q2 2018 and held it in 2 quarters.
  • Crosspoint Capital Strategies's QuidelOrtho position peaked at $1.56M in Q2 2018.
  • 158 funds tracked by Wall St. Rank held QuidelOrtho as of Q4 2018.

Based on Crosspoint Capital Strategies's 13F filing for Q4 2018, filed 13 Feb 2019.